======= UBE2Q2L ======= == Gene Information == * **Official Symbol**: UBE2Q2L * **Official Name**: ubiquitin conjugating enzyme E2 Q2 like * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=100505679|100505679]] * **UniProt**: [[https://www.uniprot.org/uniprot/H0YL09|H0YL09]] * **Interactions**: [[https://thebiogrid.org/search.php?search=UBE2Q2L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20UBE2Q2L|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A No Pfam Domain information is available for this gene. No GO term information is available for this gene. \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|-3.02| |[[:results:exp401|SNS-032 25μM R07 exp401]]|-1.94| |[[:results:exp502|Milciclib 2μM R08 exp502]]|-1.78| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|-1.77| |[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|-1.72| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.7| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.77| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|1.78| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|1.8| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|1.87| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.89| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|1.89| |[[:results:exp210|LB-100 2μM R05 exp210]]|1.9| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|1.93| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|2.01| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2.03| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|2.09| |[[:results:exp49|NFN1 0.1μM R01 exp49]]|2.24| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|2.33| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|2.56| ^Gene^Correlation^ |[[:human genes:k:kctd17|KCTD17]]|0.45| |[[:human genes:s:snrpa1|SNRPA1]]|0.448| |[[:human genes:p:psmb4|PSMB4]]|0.445| |[[:human genes:p:polr2j3|POLR2J3]]|0.443| |[[:human genes:p:psma6|PSMA6]]|0.441| |[[:human genes:b:brd2|BRD2]]|0.44| |[[:human genes:g:gid4|GID4]]|0.436| |[[:human genes:p:polr2f|POLR2F]]|0.435| |[[:human genes:a:art5|ART5]]|0.425| |[[:human genes:n:nup160|NUP160]]|0.425| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.424| |[[:human genes:v:vasn|VASN]]|0.419| |[[:human genes:c:chd4|CHD4]]|0.413| |[[:human genes:g:golga6l3|GOLGA6L3]]|0.411| |[[:human genes:t:tbc1d3l|TBC1D3L]]|0.406| |[[:human genes:t:tbc1d3e|TBC1D3E]]|0.406| |[[:human genes:t:tbc1d3k|TBC1D3K]]|0.406| |[[:human genes:t:tbc1d3i|TBC1D3I]]|0.405| |[[:human genes:t:tceb3c|TCEB3C]]|0.405| |[[:human genes:i:iscu|ISCU]]|0.4| |[[:human genes:p:psma7|PSMA7]]|0.4| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1055 * **Expression level (log2 read counts)**: -2.11 {{:chemogenomics:nalm6 dist.png?nolink |}}